Loading chart…
PRE-MARKET
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, consumer electronics, pharmaceutical, agrochemicals, paints and coatings, dyes, and personal care sectors.
Tatva Chintan Pharma Chem Limited (TATVA) is listed on the NSE in the Basic Materials sector, Specialty Chemicals industry. The TATVA share price is ₹1,624.40 (-2.16% today), with a market capitalisation of ₹38B and a price-to-earnings (P/E) ratio of 60.4. MarketRipple tracks the TATVA investment thesis, the ripple-chain impact of market events on Tatva Chintan Pharma Chem Limited, and the Basic Materials sector outlook.
Open
₹1,608.80
High
₹1,649.00
Low
₹1,603.80
Prev. Close
₹1,660.30
52W High
₹2,113.60
52W Low
₹1,044.10
Day range
₹1,603.80–₹1,649.00
52-week range
₹1,044.10–₹2,113.60
Volume
9K
P/E
60.4
ROE
8.0%
D/E
0.15
Margin
9.7%
Tatva Chintan Pharma Chem Limited (NSE: TATVA) is currently trading at ₹1,624.40 (-2.16%).
Tatva Chintan Pharma Chem Limited's market capitalization is ₹38B.
Tatva Chintan Pharma Chem Limited's price-to-earnings (P/E) ratio is 60.4.
Tatva Chintan Pharma Chem Limited operates in the Basic Materials sector (Specialty Chemicals).
Analyst consensus on Tatva Chintan Pharma Chem Limited currently reads neutral, based on 4 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.